Welcome to the Metastatic Breast Cancer Engagement Conference (June 22-23, 2018)
Conference organizers (the Metastasis Research Society and METAvivor Research and Support Inc.) invite key stakeholders in breast cancer metastasis (MBC) research and treatment to join us for this novel engagement conference June 22-23, 2018. The two-day conference, located in the Stabile Research Building of the H. Lee Moffitt Cancer Center in Tampa, FL will accommodate 250 stakeholders in both lecture-style seating and in roundtable discussion groups.
Click here for information on what the $25 registration fee includes (lunch, dinner, etc.), and to register.
Conference Continuing Education Learning Objectives
Jointly provided by USF Health, the Metastasis Research Society, and METAvivor Research and Support Inc.
1) Describe how clinical trials, including those testing experimental therapies or the novel use of existing therapies, can be applied to the treatment of metastatic breast cancer to improve outcomes and quality of life.
2) Identify how liquid biopsy blood tests can help improve the treatment of metastatic breast cancer.
3) Explain the molecular basis of breast cancer metastasis and discuss how new targets for therapy can be applied to the treatment of metastatic breast cancer to improve outcomes.
4) Identify how to optimize personalized medical decision making based upon a metastatic breast cancer patients’ desired outcomes. Competencies addressed: Patient Care and Procedural Skills and Medical/Pharmacotherapy Knowledge.
Agenda and Speakers
The agenda includes: sessions highlighting current advances in translational research and clinical MBC treatment, discussions to identify top MBC patient-desired outcomes, discussion and identification of top translational and clinical MBC research priorities addressing patient-desired outcomes, including the creation of specific clinical comparative effectiveness research questions, networking events, an educational session on resources for stakeholders, and discussions for identifying top barriers to stakeholder engagement in MBC research.
View the full agenda with session descriptions here: mbc_engagement_conference_agenda_and_sessionspeaker_descriptions.pdf
SESSIONS AND SPEAKERS
Kelly Shanahan, MD
Metastasis Research Society
Disclosure: USF Health adheres to ACCME Standards regarding commercial support of continuing medical education. It is the policy of USF Health that the faculty and planning committee disclose real or apparent conflicts of interest relating to the topics of this educational activity, that relevant conflict(s) of interest are resolved and also that speakers will disclose any unlabeled/unapproved use of drug(s) or device(s) during their presentation. Detailed disclosure will be made in the course syllabus.
Disclaimer: The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
The ** mark in the table below indicates an activity that has been approved for AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through a joint providership of USF Health and the Metastasis Research Society. USF Health is accredited by the ACCME to provide continuing medical education for physicians.
USF Health designates this live activity for a maximum of 9.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from ACCME accredited providers. Physician Assistants who participate will receive a certificate of completion commensurate with the extent of their participation.
AANPCP accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from ACCME accredited providers. Nurse Practitioners who participate will receive a certificate of completion commensurate with the extent of their participation.
If you have questions regarding credit please contact firstname.lastname@example.org, or call 813-224-7860.
USF is an Equal Opportunity / Affirmative Action / Equal Access Institution.
· Metastatic breast cancer patients, caregivers and family members
· Clinicians, clinician scientists, and translational researchers who focus on studying or treating metastatic breast cancer
· Insurance payers who cover metastatic breast cancer treatments and diagnostics
Housing and Meals
Conference registration will include snack/drink breaks, lunch, and dinner on the 22nd, and snack/drink breaks and lunch on the 23rd. The conference concludes before dinner. Breakfast is not included as nearly all hotels within 5 miles of the conference venue offer a complimentary breakfast. However, we will offer coffee, orange juice, and water in the mornings.
You are responsible for reserving and paying for your travel and lodging. Please click here to view a list of possible nearby hotel accommodations. Patients in need may apply for a limited number of patient support stipends to help cover these expenses here.
Those participating in the Metastatic Breast Cancer conference will be asked to fill out a brief pre- and post-conference survey so that organizers can evaluate the achievement of our goals and report this evaluation anonymously to our funding source, a Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington PCORI Engagement Award (6102-MRS). Registrants for the conference will also be asked to vote on top translational and clinical metastatic breast cancer research topics in a separate very brief survey. The survey will be anonymous, and results will be used to rank national research priorities for discussion at the conference in June. Top priorities will later be published and shared publicly.
This conference was organized by members of the Metastasis Research Society and collaborating partners, METAvivor Research and Support Inc. (project subcontractor), and the Sentinel Node Oncology Foundation (SNOF, project partner - Cancer Metastasis logo).
This conference was funded through a Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington PCORI Engagement Award (6102-MRS). The conference venue space was kindly donated by the H. Lee Moffitt Cancer Center in partnership with the MRS.
Copyright © Metastasis Research Conferences, All Rights Reserved 2009 - 2018
Design by Rogue Surfer